|
Clinical Trials and Observations
Citations 131-140 of 2742 total displayed.
|
Past content
(since May 1998):
|
Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapy
- Alfonso Quintás-Cardama, Hagop Kantarjian, Dan Jones, Jianqin Shan, Gautam Borthakur, Deborah Thomas, Steven Kornblau, Susan O'Brien, and Jorge Cortes
Blood 2009; 113: 6315-6321.
[Abstract]
[Full text]
[PDF]
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up
- Hagop Kantarjian, Jorge Cortes, Dong-Wook Kim, Pedro Dorlhiac-Llacer, Ricardo Pasquini, John DiPersio, Martin C. Müller, Jerald P. Radich, H. Jean Khoury, Nina Khoroshko, M. Brigid Bradley-Garelik, Chao Zhu, and Martin S. Tallman
Blood 2009; 113: 6322-6329.
[Abstract]
[Full text]
[PDF]
Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions
- Alexander G. Marneros, Marc E. Grossman, David N. Silvers, Sameera Husain, Gerard J. Nuovo, Barbara MacGregor-Cortelli, Ellen Neylon, Molly Patterson, Owen A. O'Connor, and Jasmine M. Zain
Blood 2009; 113: 6338-6341.
[Abstract]
[Full text]
[PDF]
Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study
- Ola Landgren, Robert A. Kyle, Jane A. Hoppin, Laura E. Beane Freeman, James R. Cerhan, Jerry A. Katzmann, S. Vincent Rajkumar, and Michael C. Alavanja
Blood 2009; 113: 6386-6391.
[Abstract]
[Full text]
[PDF]
Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients
- Wendi Zhou, Jeff Longmate, Simon F. Lacey, Joycelynne M. Palmer, Ghislaine Gallez-Hawkins, Lia Thao, Ricardo Spielberger, Ryotaro Nakamura, Stephen J. Forman, John A. Zaia, and Don J. Diamond
Blood 2009; 113: 6465-6476.
[Abstract]
[Full text]
[PDF]
Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation
- Emmanuel Clave, Marc Busson, Corinne Douay, Régis Peffault de Latour, Jeannig Berrou, Claire Rabian, Maryvonnick Carmagnat, Vanderson Rocha, Dominique Charron, Gérard Socié, and Antoine Toubert
Blood 2009; 113: 6477-6484.
[Abstract]
[Full text]
[PDF]
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
- Kieron Dunleavy, Stefania Pittaluga, Myron S. Czuczman, Sandeep S. Dave, George Wright, Nicole Grant, Margaret Shovlin, Elaine S. Jaffe, John E. Janik, Louis M. Staudt, and Wyndham H. Wilson
Blood 2009; 113: 6069-6076.
[Abstract]
[Full text]
[PDF]
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
- Kjeld Schmiegelow, Ibrahim Al-Modhwahi, Mette Klarskov Andersen, Mikael Behrendtz, Erik Forestier, Henrik Hasle, Mats Heyman, Jon Kristinsson, Jacob Nersting, Randi Nygaard, Anne Louise Svendsen, Kim Vettenranta, and Richard Weinshilboum, for the Nordic Society for Paediatric Haematology and Oncology
Blood 2009; 113: 6077-6084.
[Abstract]
[Full text]
[PDF]
How we treat cytomegalovirus in hematopoietic cell transplant recipients
- Michael Boeckh and Per Ljungman
Blood 2009; 113: 5711-5719.
[Abstract]
[Full text]
[PDF]
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
- John F. DiPersio, Edward A. Stadtmauer, Auayporn Nademanee, Ivana N. M. Micallef, Patrick J. Stiff, Jonathan L. Kaufman, Richard T. Maziarz, Chitra Hosing, Stefan Früehauf, Mitchell Horwitz, Dennis Cooper, Gary Bridger, Gary Calandra, and for the 3102 Investigators
Blood 2009; 113: 5720-5726.
[Abstract]
[Full text]
[PDF]
|
|
